Notable Labs Stock Quote NTBL - Stock Price, News, Charts, Message Board, Trades

Empower your portfolio: Real-time discussions and actionable trading ideas.

Premium

Current Price

0.478

Bid

0.45

Ask

0.4828

Volume

102,551

0.456 Day's Range 0.535

0.45 52 Week Range 5.27

Market Cap

4.617M

Previous Close

0.502

Open

0.531

Last Trade

0.4501

Last Trade Time

Financial Volume

$ 50,107

VWAP

0.488603

Average Volume (3m)

246,645

Shares Outstanding

9,659,496

Dividend Yield

PE Ratio

-0.39

Earnings Per Share (EPS)

-1.17

Revenue

310k

Net Profit

-11.26M

Vascular Biogenics Ltd is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of first-in-class treatments for cancer. The lead product candidate of the company is VB-111 which is a gene-based biologic which is being developed for solid tumo... Vascular Biogenics Ltd is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of first-in-class treatments for cancer. The lead product candidate of the company is VB-111 which is a gene-based biologic which is being developed for solid tumor indications for recurrent glioblastoma, an aggressive form of brain cancer. The company is also engaged in conducting a program targeting anti-inflammatory diseases, based on the use of Lecinoxoid platform technology. The product brands of the company include VTS, Vascular Targeting Systems, Vbl, Vascular Biogenics And Vascular Therapeutics. Show more

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

www.vblrx.com

Headquarters

Modi'in-maccabim-re'ut, Center, Isr

Founded

Notable Labs Ltd is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker NTBL. The last closing price for Notable Labs was $0.50. Over the last year, Notable Labs shares have traded in a share price range of $ 0.45 to $ 5.27.

Notable Labs currently has 9,659,496 shares outstanding. The market capitalization of Notable Labs is $4.85 million. Notable Labs has a price to earnings ratio (PE ratio) of -0.39.

Notable Labs Donates $60,000 to MDS Foundation to Accelerate Progress for Patients with Myelodysplastic Syndromes

Notable Labs Donates $60,000 to MDS Foundation to Accelerate Progress for Patients with Myelodysplastic Syndromes PR Newswire SAN DIEGO, Dec. 13, 2023 Funds will help advance MDS Education...

Notable Labs Funds Myelodysplastic Syndromes Foundation with $60,000 Grant

Notable Labs Funds Myelodysplastic Syndromes Foundation with $60,000 Grant PR Newswire SAN DIEGO, Dec. 11, 2023 Funds will help advance MDS Education, Advocacy and Research SAN DIEGO, Dec. 11...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	-0.0923	-16.184464317	0.5703	0.65	0.45	46354	0.55517219	CS
4	-0.252	-34.5205479452	0.73	0.808	0.45	90861	0.61457519	CS
12	-1.102	-69.746835443	1.58	1.94	0.45	246645	1.22461043	CS
26	-4.022	-89.3777777778	4.5	5.27	0.45	197694	1.3628179	CS
52	-4.022	-89.3777777778	4.5	5.27	0.45	197694	1.3628179	CS
156	-4.022	-89.3777777778	4.5	5.27	0.45	197694	1.3628179	CS
260	0	0	0	0.54	0	0	0	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
NOVVUNova Vision Acquisition Corporation	$ 41.00 (207.35%)	17.4k
NOVVNova Vision Acquisition Corporation	$ 37.0001 (200.08%)	205.22k
SMXSMX Security Matters Public Company	$ 5.85 (138.78%)	50.1M
OMICSingular Genomics Systems Inc	$ 12.38 (119.12%)	2.87M
TILInstill Bio Inc	$ 84.75 (82.41%)	3.91M
GSIWGarden Stage Ltd	$ 2.9693 (-75.66%)	4.21M
UPCUniverse Pharmaceuticals Inc	$ 0.55 (-67.07%)	29.83M
VMARVision Marine Technologies Inc	$ 0.77 (-48.67%)	30.61M
PRLDPrelude Therapeutics Inc	$ 2.775 (-42.55%)	2.49M
CNEYCN Energy Group Inc	$ 0.4335 (-37.17%)	4.79M
NVDANVIDIA Corporation	$ 119.10 (-0.03%)	225.83M
XXII22nd Century Group Inc	$ 0.3447 (28.00%)	168.56M
IMRXImmuneering Corporation	$ 2.02 (41.26%)	131.85M
SQQQProShares UltraPro Short QQQ	$ 8.17 (-1.33%)	122.46M
MULNMullen Automotive Inc	$ 0.1328 (-20.48%)	119.52M